Coronavirus disease 2019 (COVID-19) exhibits variable symptom severity ranging from
asymptomatic to life-threatening, yet the relationship between severity and the humoral immune …

We measured plasma and/or serum antibody responses to the receptor-binding domain (RBD)
of the spike (S) protein of SARS-CoV-2 in 343 North American patients infected with …

Appropriate use and interpretation of serological tests for assessments of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) exposure, infection and potential immunity …

Appropriate use and interpretation of serological tests for assessments of SARS-CoV-2
exposure, infection and potential immunity require accurate assay performance data. We …

Background Understanding immunogenicity and effectiveness of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) vaccines is critical to guide rational use. Methods We …

The diagnosis of COVID‐19 requires integration of clinical and laboratory data. Severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2) diagnostic assays play a central role in …

Critical to managing the spread of COVID-19 is the ability to diagnose infection and define
the acquired immune response across the population. While genomic tests for the novel …

SARS-CoV-2 antibody testing allows quantitative determination of disease prevalence, which
is especially important in high-risk communities. We performed anonymized convenience …

Sensitive and specific severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
serologic assays are needed to inform diagnostic, therapeutic, and public health decision-making…

As somatic cells are converted into induced pluripotent stem cells (iPSCs), their chromatin is
remodeled to a pluripotent configuration with unique euchromatin-to-heterochromatin ratios, …